Functional connectivity and topology in patients with restless legs syndrome: a case-control resting-state functional magnetic resonance imaging study.
brain connectivity
functional magnetic resonance imaging
restless legs syndrome
sleep wake disorders
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
29
07
2020
revised:
29
09
2020
accepted:
05
10
2020
pubmed:
9
10
2020
medline:
13
8
2021
entrez:
8
10
2020
Statut:
ppublish
Résumé
Functional connectivity studies revealed alterations within thalamic, salience, and default mode networks in restless legs syndrome patients. Eighty-two patients with restless legs syndrome (untreated, n = 30; on dopaminergic medication, n = 42; on alpha-2-delta ligands as mono- or polytherapy combined with dopaminergic medication, n = 10), and 82 individually age- and gender-matched healthy controls were studied with resting-state functional magnetic resonance imaging. Connectivity of 12 resting-state networks was investigated with independent component analysis, and network topology was studied with graph methods among 410 brain regions. Patients with restless legs syndrome showed significantly higher connectivity within salience (p = 0.029), executive (p = 0.001), and cerebellar (p = 0.041) networks, as well as significantly lower (p < 0.05) cerebello-frontal communication compared to controls. In addition, they had a significantly higher (p < 0.05) clustering coefficient and local efficiency in motor and frontal regions; lower clustering coefficient in the central sulcus; and lower local efficiency in the central opercular cortex, temporal, parieto-occipital, cuneus, and occipital regions compared to controls. Untreated patients had significantly lower (p < 0.05) cerebello-parietal communication compared to healthy controls. Connectivity between the thalamus and frontal regions was significantly increased (p < 0.05) in patients on dopaminergic medication compared to untreated patients and controls. Networks with higher intranetwork connectivity (i.e., salience, executive, cerebellar) and lower cerebello-frontal connectivity in the restless legs syndrome patients, as well as lower cerebello-parietal connectivity in untreated patients, correspond to regions associated with attention, response inhibitory control, and processing of sensory information. Intact cerebello-parietal communication and increased thalamic connectivity to the prefrontal regions in patients on dopaminergic medication suggests a treatment effect on thalamus.
Sections du résumé
BACKGROUND AND PURPOSE
Functional connectivity studies revealed alterations within thalamic, salience, and default mode networks in restless legs syndrome patients.
METHODS
Eighty-two patients with restless legs syndrome (untreated, n = 30; on dopaminergic medication, n = 42; on alpha-2-delta ligands as mono- or polytherapy combined with dopaminergic medication, n = 10), and 82 individually age- and gender-matched healthy controls were studied with resting-state functional magnetic resonance imaging. Connectivity of 12 resting-state networks was investigated with independent component analysis, and network topology was studied with graph methods among 410 brain regions.
RESULTS
Patients with restless legs syndrome showed significantly higher connectivity within salience (p = 0.029), executive (p = 0.001), and cerebellar (p = 0.041) networks, as well as significantly lower (p < 0.05) cerebello-frontal communication compared to controls. In addition, they had a significantly higher (p < 0.05) clustering coefficient and local efficiency in motor and frontal regions; lower clustering coefficient in the central sulcus; and lower local efficiency in the central opercular cortex, temporal, parieto-occipital, cuneus, and occipital regions compared to controls. Untreated patients had significantly lower (p < 0.05) cerebello-parietal communication compared to healthy controls. Connectivity between the thalamus and frontal regions was significantly increased (p < 0.05) in patients on dopaminergic medication compared to untreated patients and controls.
CONCLUSIONS
Networks with higher intranetwork connectivity (i.e., salience, executive, cerebellar) and lower cerebello-frontal connectivity in the restless legs syndrome patients, as well as lower cerebello-parietal connectivity in untreated patients, correspond to regions associated with attention, response inhibitory control, and processing of sensory information. Intact cerebello-parietal communication and increased thalamic connectivity to the prefrontal regions in patients on dopaminergic medication suggests a treatment effect on thalamus.
Identifiants
pubmed: 33032390
doi: 10.1111/ene.14577
pmc: PMC7820983
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
448-458Informations de copyright
© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
J Neurosci. 2017 Jun 7;37(23):5594-5607
pubmed: 28450543
Sleep Med. 2016 Jul;23:6-11
pubmed: 27692278
Sleep Med. 2017 Mar;31:61-70
pubmed: 28057495
Sleep Med. 2017 Mar;31:71-77
pubmed: 27539027
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):19900-9
pubmed: 23086162
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Sleep. 2019 Dec 24;42(12):
pubmed: 31555830
Front Psychol. 2017 Sep 20;8:1621
pubmed: 28979226
Ann Neurol. 1997 May;41(5):639-45
pubmed: 9153526
J Neurosci Methods. 2015 Oct 30;254:46-59
pubmed: 26213217
Sleep Med Clin. 2015 Sep;10(3):207-14, xi
pubmed: 26329430
Sleep Med. 2008 Jan;9(2):177-83
pubmed: 17638594
Sleep Med. 2016 Apr;20:116-22
pubmed: 27318235
Hum Brain Mapp. 2009 Jul;30(7):2252-66
pubmed: 19107748
Sleep Med. 2003 Mar;4(2):101-19
pubmed: 14592341
Sleep Med. 2017 Oct;38:96-103
pubmed: 29031764
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Brain. 2013 Jul;136(Pt 7):e234
pubmed: 23370091
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Front Neurosci. 2017 Mar 13;11:115
pubmed: 28348512
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
Trends Cogn Sci. 2007 Jun;11(6):229-35
pubmed: 17475536
AJNR Am J Neuroradiol. 2012 Apr;33(4):667-72
pubmed: 22173758
Sleep Med. 2020 Mar;67:33-38
pubmed: 31887606
Ther Adv Neurol Disord. 2020 Aug 3;13:1756286420941670
pubmed: 32821291
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
Ann Clin Transl Neurol. 2018 Jan 30;5(3):315-322
pubmed: 29560376
Sleep Med. 2003 Mar;4(2):121-32
pubmed: 14592342
Cereb Cortex. 2012 Aug;22(8):1862-75
pubmed: 21968567
J Neurophysiol. 2010 Jan;103(1):297-321
pubmed: 19889849
Neurology. 2013 May 28;80(22):2028-34
pubmed: 23624560
Nat Rev Neurosci. 2012 Apr 13;13(5):336-49
pubmed: 22498897
Neuroimage. 2003 Sep;20(1):351-8
pubmed: 14527595
Sleep Med. 2018 Jan;41:1-8
pubmed: 29425573
Brain. 2012 Dec;135(Pt 12):3712-20
pubmed: 23183234
Trends Cogn Sci. 2013 Dec;17(12):683-96
pubmed: 24231140
J Neurosci. 2009 Jul 1;29(26):8586-94
pubmed: 19571149
Mov Disord. 2008 Jul 15;23(9):1250-5
pubmed: 18464282
Brain. 2006 Aug;129(Pt 8):2017-28
pubmed: 16816393
Neurology. 2008 Sep 16;71(12):911-6
pubmed: 18794493
Lancet Neurol. 2017 Nov;16(11):898-907
pubmed: 29029846
Sleep Med. 2014 Mar;15(3):289-94
pubmed: 24555993
Phys Rev Lett. 2001 Nov 5;87(19):198701
pubmed: 11690461
Neurosci Lett. 2016 Mar 23;617:264-9
pubmed: 26921454
Sleep Med. 2018 May;45:132-139
pubmed: 29680421
J Neurosci. 2014 Nov 12;34(46):15340-6
pubmed: 25392501
Sleep Med. 2017 Mar;31:39-48
pubmed: 27838239